Vera Therapeutics Stock (NASDAQ: VERA) stock price, news, charts, stock research, profile.
Open | $35.35 |
Close | $36.18 |
Volume / Avg. | 1.91M / 916.31K |
Day Range | 34.88 - 36.64 |
52 Wk Range | 9.24 - 50.78 |
Market Cap | $2.00B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 16.53% |
Days to Cover | 8.68 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vera Therapeutics (NASDAQ:VERA) through any online brokerage.
Other companies in Vera Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Agios Pharmaceuticals (NASDAQ:AGIO), Apogee Therapeutics (NASDAQ:APGE) and Novavax (NASDAQ:NVAX).
There is no analysis for Vera Therapeutics.
Vera Therapeutics has a consensus price target of $31.70.
The stock price for Vera Therapeutics (NASDAQ: VERA) is $36.5 last updated June 28, 2024 at 4:26 PM EDT.
A quarterly cash dividend of 0.02 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on January 10, 1996.
Vera Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Vera Therapeutics.
Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.